| A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers S Ganta, D Deshpande, A Korde, M Amiji Molecular membrane biology 27 (7), 260-273, 2010 | 106 | 2010 |
| Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice. LB Kwang Hwa Jung, Wonbeak Yoo, Heather L Stevenson, Dipti Deshpande, Hong ... Clin Cancer Res, 2017 | 95 | 2017 |
| Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles D Deshpande, H Devalapally, M Amiji Pharmaceutical research 25, 1936-1947, 2008 | 39 | 2008 |
| Therapeutic efficacy of an ω-3-fatty acid-containing 17-β estradiol nano-delivery system against experimental atherosclerosis D Deshpande, S Kethireddy, DR Janero, MM Amiji PLoS One 11 (2), e0147337, 2016 | 23 | 2016 |
| Comparative pharmacokinetics and tissue distribution analysis of systemically administered 17-β-estradiol and its metabolites in vivo delivered using a cationic nanoemulsion or … D Deshpande, S Kethireddy, F Gattacceca, M Amiji Journal of controlled release 180, 117-124, 2014 | 18 | 2014 |
| Engineering of an ω-3 polyunsaturated fatty acid-containing nanoemulsion system for combination C6-ceramide and 17β-estradiol delivery and bioactivity in human vascular … D Deshpande, DR Janero, M Amiji Nanomedicine: Nanotechnology, Biology and Medicine 9 (7), 885-894, 2013 | 18 | 2013 |
| Therapeutic strategies for endothelial dysfunction DD Deshpande, DR Janero, MM Amiji Expert opinion on biological therapy 11 (12), 1637-1654, 2011 | 14 | 2011 |
| Nucleic acid delivery for endothelial dysfunction in cardiovascular diseases D Deshpande, DR Janero, V Segura-Ibarra, E Blanco, MM Amiji Methodist DeBakey cardiovascular journal 12 (3), 134, 2016 | 6 | 2016 |
| Role of eco-friendly strategies in the development of biomedical nanotechnology S Ganta, S Chadwick, D Deshpande, M Amiji International Journal of Green Nanotechnology: Biomedicine 1 (1), B9-B23, 2009 | 2 | 2009 |
| Efficacy of the FXR agonist, MET409, in male and female mouse models of NASH and fibrosis B Wagner, A Milik, H Mondala, S Govek, J Nagasawa, K Douglas, KJ Lee, ... HEPATOLOGY 66, 1071A-1071A, 2017 | 1 | 2017 |
| The MetAP2 Inhibitor, Zgn-1061, Improves Metabolic Parameters and Hepatic Pathology in Mouse Models of Diabetes and Nonalcoholic Steatohepatitis or Hepatocellular Carcinoma B Burkey, M Illemann, S Veidal, M Feigh, M Briggs, D Deshpande, ... HEPATOLOGY 68, 443A-443A, 2018 | | 2018 |
| Metabolic disease drivers of liver cancer, a new disease paradigm MR Briggs, D Deshpande, N Siegmund Cancer Research 78 (13_Supplement), 4088-4088, 2018 | | 2018 |
| Nanotechnology Applications in Local Arterial Drug Delivery D Deshpande, A Jamal-Allial, K Sankhe, M Amiji Focal Controlled Drug Delivery, 359-385, 2014 | | 2014 |
| Evaluation of a Novel Anti-inflammatory Estradiol-Loaded Omega-3-Fatty Acid Oil Containing Nanoemulsion Formulation for the Treatment of Atherosclerosis D Deshpande, K Sankhe, M Amiji | | |
